Here is a recap of every FDA approval announced by the regulatory agency in the month of April, spanning various cancer types ...

The FDA has issued a Complete Response Letter to Telix Pharmaceuticals regarding the NDA for TLX101-CDx for the imaging of gliomas.

A new drug application seeking the approval of ziftomenib was submitted to the FDA on April 8, 2025. This indication is for ...

Linked to thyroid cancer in rats, Red dye No. 3 is now banned in the US -- but it'll take time to phase out completely.

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...

No, red dye 3 and red dye 40 are not the same. Red dye 40, made of a chemical compound called Allura red AC, is already ...

A major clinical trial reveals Wegovy a popular weight loss drug also treats serious liver disease MASH—reducing liver inflammation and scarring in most patients ...

At AACR 2025, zongertinib showed promising results in HER2-mutant NSCLC with high response rates, durable control, and a ...

Clinicians worldwide regard (Pluvicto) as a significant breakthrough therapy for patients with advanced disease' ...

SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment ...

So the campaign to make recreational weed legal in Florida failed. What do you do? If you are Curaleaf, you open a hemp-only ...

Amgen AMGN reported first-quarter 2025 adjusted earnings of $4.90 per share, which beat the Zacks Consensus Estimate of $4.16 ...